Pulmonary Function Test Changes and Respiratory Muscle Strength Trends in Spinal Muscular Atrophy Patients Receiving Nusinersen Treatments

NCT04050852 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped no enrolled prospects

Conditions

Spinal Muscular Atrophy

Interventions

DRUG: Nusinersen Treatments

Sponsor

NYU Langone Health

Collaborators

[object Object]